Rat and human hippocampal alpha5 subunit-containing gamma-aminobutyric AcidA receptors have alpha5 beta3 gamma2 pharmacological characteristics - PubMed (original) (raw)
Rat and human hippocampal alpha5 subunit-containing gamma-aminobutyric AcidA receptors have alpha5 beta3 gamma2 pharmacological characteristics
C Sur et al. Mol Pharmacol. 1998 Nov.
Abstract
The gamma-aminobutyric acid (GABA)A receptor is a hetero-oligomer consisting of five subunits, the combination of which confers unique pharmacological properties to the receptor. To understand the physiological role of native GABAA receptors, it is critical to determine their subunit compositions. The pharmacological characteristics of human alpha5 beta3 gamma2 and alpha5beta3gamma3 GABAA receptors stably expressed in L(tk-) cells were characterized with the alpha5-selective ligand [3H]L-655,708 and compared with the pharmacological characteristics of [3H]L-655,708 binding sites from rat and human hippocampus. Saturation analyses revealed a 9-fold selective affinity of [3H]L-655,708 for alpha5 beta3 gamma2 receptors (Kd = 1.7 +/- 0.4 nM), compared with alpha5 beta3 gamma3 receptors (Kd = 15 +/- 3 nM). Rat and human hippocampal [3H]L-655,708 binding sites had affinities of 2.2 +/- 0.6 and 1.0 +/- 0.2 nM, respectively, comparable to the affinity of alpha5 beta3 gamma2 receptors. Pharmacological analysis of [3H]L-655,708 binding sites in rat and human hippocampi revealed a strong correlation with the affinities of seven benzodiazepine site ligands for alpha5 beta3 gamma2 but not alpha5 beta3 gamma3 receptors. Immunoprecipitation of [3H]L-655,708 binding sites from rat hippocampus with a gamma2-selective antibody yielded 19 +/- 4% of total benzodiazepine binding sites measured using [3H]Ro15-1788, whereas no specific binding was measured after immunoprecipitation with an anti-gamma3 antibody. Combinatorial immunoprecipitations of [3H]muscimol binding sites with anti-alpha5 and anti-gamma2 or anti-alpha5 and anti-gamma3 antibodies established the preferential expression of alpha5 gamma2 receptors, accounting for 22 +/- 2% of total rat hippocampal GABAA receptors. These observations provide pharmacological and structural evidence for the prevalence of alpha5 beta3 gamma2 GABAA receptors in rat hippocampus, despite the clustering of alpha5 and gamma3 loci on the same chromosome.
Similar articles
- Molecular and pharmacological characterization of native cortical gamma-aminobutyric acidA receptors containing both alpha1 and alpha3 subunits.
Araujo F, Tan S, Ruano D, Schoemaker H, Benavides J, Vitorica J. Araujo F, et al. J Biol Chem. 1996 Nov 1;271(44):27902-11. doi: 10.1074/jbc.271.44.27902. J Biol Chem. 1996. PMID: 8910390 - Ethyl 8-fluoro-5-[11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate.
Chopra A. Chopra A. 2008 Apr 28 [updated 2008 Jun 10]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Apr 28 [updated 2008 Jun 10]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641752 Free Books & Documents. Review. - Structural and pharmacological aspects of the GABAA receptor: involvement in behavioral pathogenesis.
Clément Y. Clément Y. J Physiol Paris. 1996;90(1):1-13. doi: 10.1016/0928-4257(96)87164-6. J Physiol Paris. 1996. PMID: 8803850 Review.
Cited by
- Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors.
Jacob TC. Jacob TC. Front Mol Neurosci. 2019 Jul 24;12:179. doi: 10.3389/fnmol.2019.00179. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31396049 Free PMC article. - Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model.
Braudeau J, Dauphinot L, Duchon A, Loistron A, Dodd RH, Hérault Y, Delatour B, Potier MC. Braudeau J, et al. Adv Pharmacol Sci. 2011;2011:153218. doi: 10.1155/2011/153218. Epub 2011 Oct 19. Adv Pharmacol Sci. 2011. PMID: 22028705 Free PMC article. - Αlpha 5 subunit-containing GABAA receptors in temporal lobe epilepsy with normal MRI.
McGinnity CJ, Riaño Barros DA, Hinz R, Myers JF, Yaakub SN, Thyssen C, Heckemann RA, de Tisi J, Duncan JS, Sander JW, Lingford-Hughes A, Koepp MJ, Hammers A. McGinnity CJ, et al. Brain Commun. 2021 Jan 7;3(1):fcaa190. doi: 10.1093/braincomms/fcaa190. eCollection 2021. Brain Commun. 2021. PMID: 33501420 Free PMC article. - Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer.
Rashid Roni MS, Zahn NM, Yocum GT, Webb DA, Mian MY, Meyer MJ, Tylek AS, Cook JM, Emala CW, Stafford DC, Arnold LA. Rashid Roni MS, et al. Drug Dev Res. 2022 Jun;83(4):979-992. doi: 10.1002/ddr.21926. Epub 2022 Mar 4. Drug Dev Res. 2022. PMID: 35246861 Free PMC article. - A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABAA Receptor.
Li G, Nieman AN, Mian MY, Zahn NM, Mikulsky BN, Poe MM, Methuku KR, Liu Y, Cook JM, Stafford DC, Arnold LA. Li G, et al. Molecules. 2020 Aug 25;25(17):3864. doi: 10.3390/molecules25173864. Molecules. 2020. PMID: 32854311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources